| |
Latest 10 SEC filings (by transaction date) for AMRX within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 14/24 | Mar 12/24 | Konidaris Tasos | Direct Ownership | Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -87,720 | |
Mar 14/24 | Mar 12/24 | Konidaris Tasos | Direct Ownership | Class A Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -30,790 | $5.31 |
Mar 14/24 | Mar 12/24 | Konidaris Tasos | Direct Ownership | Class A Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 87,720 | |
Mar 6/24 | Mar 4/24 | Patel Chintu | Direct Ownership | Performance-Based Restricted Stock Units | A - Grant, award or other under Rule 16b-3(d) | 1,333,334 | |
Mar 6/24 | Mar 4/24 | Patel Chintu | Direct Ownership | Restricted Stock Units | A - Grant, award or other under Rule 16b-3(d) | 370,370 | |
Mar 6/24 | Mar 4/24 | Patel Chirag K. | Direct Ownership | Performance-Based Restricted Stock Units | A - Grant, award or other under Rule 16b-3(d) | 1,333,334 | |
Mar 6/24 | Mar 4/24 | Patel Chirag K. | Direct Ownership | Restricted Stock Units | A - Grant, award or other under Rule 16b-3(d) | 370,370 | |
Mar 5/24 | Mar 4/24 | Konidaris Tasos | Direct Ownership | Performance-Based Restricted Stock Units | A - Grant, award or other under Rule 16b-3(d) | 351,852 | |
Mar 5/24 | Mar 4/24 | Konidaris Tasos | Direct Ownership | Restricted Stock Units | A - Grant, award or other under Rule 16b-3(d) | 175,926 | |
Mar 5/24 | Mar 4/24 | Daly Jason B. | Direct Ownership | Performance-Based Restricted Stock Units | A - Grant, award or other under Rule 16b-3(d) | 287,038 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for AMRX within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 14/24 | Mar 12/24 | Konidaris Tasos | Direct Ownership | Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -87,720 | |
Mar 14/24 | Mar 12/24 | Konidaris Tasos | Direct Ownership | Class A Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -30,790 | $5.31 |
Mar 14/24 | Mar 12/24 | Konidaris Tasos | Direct Ownership | Class A Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 87,720 | |
Mar 6/24 | Mar 4/24 | Patel Chintu | Direct Ownership | Performance-Based Restricted Stock Units | A - Grant, award or other under Rule 16b-3(d) | 1,333,334 | |
Mar 6/24 | Mar 4/24 | Patel Chintu | Direct Ownership | Restricted Stock Units | A - Grant, award or other under Rule 16b-3(d) | 370,370 | |
Mar 6/24 | Mar 4/24 | Patel Chirag K. | Direct Ownership | Performance-Based Restricted Stock Units | A - Grant, award or other under Rule 16b-3(d) | 1,333,334 | |
Mar 6/24 | Mar 4/24 | Patel Chirag K. | Direct Ownership | Restricted Stock Units | A - Grant, award or other under Rule 16b-3(d) | 370,370 | |
Mar 5/24 | Mar 3/24 | Konidaris Tasos | Direct Ownership | Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -57,339 | |
Mar 5/24 | Mar 3/24 | Konidaris Tasos | Direct Ownership | Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -45,290 | |
Mar 5/24 | Mar 1/24 | Konidaris Tasos | Direct Ownership | Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -36,197 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Eyepoint Pharmaceuticals (OQ:EYPT) |
AbbVie (N:ABBV) |
Merck & Co (N:MRK) |